However, there are also some studies that point in the opposite direction in obese subjects without T2D, showing an inverse relationship between serum levels of sclerostin and subclinical carotid atherosclerosis as well as absence of relationship between sclerostin and parameters of cardiovascular risk. This evidence concerns the gene SOST and type 2 diabetes mellitus.